WIC
TMO icon

WealthBridge Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

WealthBridge Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44M Buy
12,852
+275
+2% +$132K 1.72% 24
2026
Q1 		$6.18M Buy
12,577
+187
+2% +$101K 1.89% 26
2025
Q4 		$7.18M Buy
12,390
+440
+4% +$249K 2.15% 25
2025
Q3 		$5.8M Buy
11,950
+225
+2% +$105K 1.79% 29
2025
Q2 		$4.75M Buy
11,725
+238
+2% +$99.5K 1.54% 29
2025
Q1 		$5.72M Buy
11,487
+265
+2% +$144K 2.08% 25
2024
Q4 		$5.84M Buy
11,222
+105
+0.9% +$57.7K 2.14% 26
2024
Q3 		$6.88M Buy
11,117
+225
+2% +$133K 2.44% 22
2024
Q2 		$6.02M Buy
10,892
+417
+4% +$239K 2.3% 22
2024
Q1 		$6.09M Sell
10,475
-10
-0.1% -$5.61K 2.26% 24
2023
Q4 		$5.57M Buy
10,485
+24
+0.2% +$11.6K 2.23% 26
2023
Q3 		$5.29M Buy
10,461
+221
+2% +$118K 2.31% 22
2023
Q2 		$5.34M Buy
10,240
+1,170
+13% +$631K 2.25% 24
2023
Q1 		$5.23M Buy
9,070
+215
+2% +$121K 2.31% 24
2022
Q4 		$4.88M Buy
8,855
+728
+9% +$386K 2.13% 25
2022
Q3 		$4.12M Buy
8,127
+585
+8% +$327K 2.17% 26
2022
Q2 		$4.1M Buy
7,542
+350
+5% +$193K 2.08% 28
2022
Q1 		$4.25M Buy
7,192
+507
+8% +$291K 1.88% 29
2021
Q4 		$4.46M Sell
6,685
-10
-0.1% -$6.24K 1.89% 27
2021
Q3 		$3.83M Sell
6,695
-150
-2% -$82.3K 1.72% 27
2021
Q2 		$3.45M Buy
6,845
+580
+9% +$274K 1.53% 29
2021
Q1 		$2.86M Buy
6,265
+365
+6% +$174K 1.4% 29
2020
Q4 		$2.75M Buy
5,900
+430
+8% +$202K 1.44% 29
2020
Q3 		$2.42M Buy
5,470
+135
+3% +$55.8K 1.47% 28
2020
Q2 		$1.93M Buy
5,335
+75
+1% +$25.1K 1.28% 28
2020
Q1 		$1.49M Buy
5,260
+175
+3% +$55.2K 1.27% 26
2019
Q4 		$1.65M Buy
+5,085
New +$1.54M 0.94% 32

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

WealthBridge Investment Counsel's TMO Position: Q2 2026 in Review

WealthBridge Investment Counsel increased its Thermo Fisher Scientific (TMO) stake by 2.2% in Q2 2026, buying an estimated $132K and bringing the position to 12,852 shares worth $6.44M. The position accounts for 1.72% of the portfolio, ranked #24.

WealthBridge Investment Counsel first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.18M in Q4 2025. 1,194 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • WealthBridge Investment Counsel held 12,852 shares of Thermo Fisher Scientific worth $6.44M as of Q2 2026.
  • WealthBridge Investment Counsel bought 275 Thermo Fisher Scientific shares in Q2 2026, an estimated $132K.
  • Thermo Fisher Scientific made up 1.72% of WealthBridge Investment Counsel's portfolio in Q2 2026, its #24 holding.
  • WealthBridge Investment Counsel first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • WealthBridge Investment Counsel's Thermo Fisher Scientific position peaked at $7.18M in Q4 2025.
  • 1,194 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on WealthBridge Investment Counsel's 13F filing for Q2 2026, filed 15 Jul 2026.